Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity

S. Kurekova, L. Pavlikova, M. Seres, V. Bohacova, J. Spaldova, A. Breier, Z. Sulova

. 2025 ; 25 (1) : 35. [pub] 20250207

Status not-indexed Language English Country England, Great Britain

Document type Journal Article

Grant support
VEGA 2/0070/19, VEGA 2/0159/19 VEGA 2/0171/21, VEGA2/0046/24 Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences
APVV-19-0093 Slovak Agency for Research and Development

In previous research, we revealed that murine leukemia cells L1210 with induced expression of P-glycoprotein (P-gp, a membrane drug transporter, product of the Abcb1 gene) are better able to withstand endoplasmic reticulum (ER) stress (ERS) than their P-gp negative counterparts. This was associated with increased GRP78/BiP expression and modulation of the expression of several other proteins active in the cellular response to ERS (like CHOP, spliced XBP1, 50-kDa ATF6 protein fragment and others) in P-gp positive cells. Wolframin is an ER transmembrane protein, product of the WFS1 gene whose mutations are associated with Wolfram syndrome. However, this protein is frequently overexpressed in cells undergoing ERS and its expression may accompany changes in the above ERS markers. Therefore, our aim in this work was to investigate wolframin expression in P-gp-negative and P-gp-positive murine leukemia L1210 cells in relation to ERS related proteins in normal or ERS condition. We induced ERS in cells either by blocking N-glycosylation in the ER with tunicamycin or by blocking ER Ca2+-ATPase activity with thapsigargin, as known ER stressors. The results of this paper demonstrated increased wolframin expression in P-gp positive cells compared to P-gp negative cells. Immunoprecipitation experiments revealed the formation of complexes between wolframin and ERS related proteins (PERK, ATF6 and GRP78/BiP), the amount of which varied depending on the presence of the above ER stressors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25008459
003      
CZ-PrNML
005      
20250422095621.0
007      
ta
008      
250408s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12935-025-03661-w $2 doi
035    __
$a (PubMed)39920654
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kurekova, Simona $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia $u Institute of Biology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 775 15, Olomouc, Czechia
245    10
$a Do wolframin, P-glycoprotein, and GRP78/BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity / $c S. Kurekova, L. Pavlikova, M. Seres, V. Bohacova, J. Spaldova, A. Breier, Z. Sulova
520    9_
$a In previous research, we revealed that murine leukemia cells L1210 with induced expression of P-glycoprotein (P-gp, a membrane drug transporter, product of the Abcb1 gene) are better able to withstand endoplasmic reticulum (ER) stress (ERS) than their P-gp negative counterparts. This was associated with increased GRP78/BiP expression and modulation of the expression of several other proteins active in the cellular response to ERS (like CHOP, spliced XBP1, 50-kDa ATF6 protein fragment and others) in P-gp positive cells. Wolframin is an ER transmembrane protein, product of the WFS1 gene whose mutations are associated with Wolfram syndrome. However, this protein is frequently overexpressed in cells undergoing ERS and its expression may accompany changes in the above ERS markers. Therefore, our aim in this work was to investigate wolframin expression in P-gp-negative and P-gp-positive murine leukemia L1210 cells in relation to ERS related proteins in normal or ERS condition. We induced ERS in cells either by blocking N-glycosylation in the ER with tunicamycin or by blocking ER Ca2+-ATPase activity with thapsigargin, as known ER stressors. The results of this paper demonstrated increased wolframin expression in P-gp positive cells compared to P-gp negative cells. Immunoprecipitation experiments revealed the formation of complexes between wolframin and ERS related proteins (PERK, ATF6 and GRP78/BiP), the amount of which varied depending on the presence of the above ER stressors.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pavlikova, Lucia $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
700    1_
$a Seres, Mario $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
700    1_
$a Bohacova, Viera $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia
700    1_
$a Spaldova, Jana $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237, Bratislava, Slovakia
700    1_
$a Breier, Albert $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia. albert.breier@stuba.sk $u Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237, Bratislava, Slovakia. albert.breier@stuba.sk
700    1_
$a Sulova, Zdena $u Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Dúbravská Cesta 9, 840 05, Bratislava, Slovakia. zdena.sulova@savba.sk
773    0_
$w MED00008210 $t Cancer cell international $x 1475-2867 $g Roč. 25, č. 1 (2025), s. 35
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39920654 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250408 $b ABA008
991    __
$a 20250422095622 $b ABA008
999    __
$a ok $b bmc $g 2306381 $s 1245534
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 25 $c 1 $d 35 $e 20250207 $i 1475-2867 $m Cancer cell international $n Cancer Cell Int $x MED00008210
GRA    __
$a VEGA 2/0070/19, VEGA 2/0159/19 VEGA 2/0171/21, VEGA2/0046/24 $p Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences
GRA    __
$a APVV-19-0093 $p Slovak Agency for Research and Development
LZP    __
$a Pubmed-20250408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...